Stocks to sell

Lemonade (NASDAQ:LMND) stock has caught investors’ attention, and for pretty good reason. Source: Stephanie L Sanchez / Shutterstock.com If Amazon’s (NASDAQ:AMZN) taught us anything over the past few decades, it’s the power of disruption, and the value of recognising it early. That’s part of the reason that insurance disruptor Lemonade is so attractive. LMND stock
0 Comments
After months of sideways price action, Covid-19 vaccine play Ocugen (NASDAQ:OCGN) stock is zooming higher once. Source: shutterstock.com/PhotobyTawat The big development is a likely Emergency Use Listing (EUL) from the World Health Organization (WHO) for Covaxin. Developed in India by Bharat Biotech, Ocugen holds the U.S. and Canadian rights to market this vaccine. An EUL certainly
0 Comments
Just over a year ago, Hyliion (NYSE:HYLN) was one of the hottest electric vehicle special-purpose acquisition company (SPAC) plays out there. Just before its “de-SPACing,” excitement over this maker of electric trucks and powertrains briefly sent HYLN stock to prices over $50 per share. Source: Shutterstock Flash forward back to now, and where are shares changing
0 Comments
To put it succinctly, there isn’t very much making Lemonade (NYSE:LMND) stock attractive at present. Source: Stephanie L Sanchez / Shutterstock.com Yes, there’s news that the insurance company is launching a new service for pets. That will expand the company’s product mix beyond life, homeowners, and renters insurance. And Lemonade already announced a car insurance
0 Comments